#AmantaHealthcareIPO #IPOListing #StockMarketIndia #NSE #BSE #InvestorConfidence #PharmaSector #GreyMarketPremium #SterileInjectables #EquityMarkets

#AmantaHealthcareIPO #IPOListing #StockMarketIndia #NSE #BSE #InvestorConfidence #PharmaSector #GreyMarketPremium #SterileInjectables #EquityMarkets By Staff Reporter | September 8, 2025 Mumbai: Amanta Healthcare Ltd made a steady entry into the Indian stock market today, as its shares debuted at a 7% premium to the issue price on the National Stock Exchange (NSE). The stock opened at ₹136 per share, compared to its issue price of ₹127, reflecting strong but measured investor confidence. The performance closely aligned with predictions from the grey market, where the stock had been quoting at a premium of about ₹9 per share, translating into a 7.14% upside. The listing…